Homology modeling of transporter proteins (carriers and ion channels)

Methods in Molecular Biology

Volumn 857, Issue , 2012, Pages 281-299

  Ravna, Aina Westrheim ^a   Sylte, Ingebrigt ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

ABC transporters; Amino acid sequence alignments; Carriers; Drug targets; Homology modeling; Ion channels; Model building and refinements; Model evaluation; Neurotransmitter transporters

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; ION CHANNEL;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; HUMANS; ION CHANNELS; MODELS, MOLECULAR; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84858133323     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-588-6_12     Document Type: Article

References (58)

1. Landry Y, Gies JP (2008) Drugs and their molecular targets: An updated overview. Fundam Clin Pharmacol 22:1-18 (Pubitemid 351171284)
2. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236
3. Saier MH, Jr. (2000) A functional-phylogenetic classifi cation system for transmembrane solute transporters. Microbiol Mol Biol Rev 64:354-411 (Pubitemid 30412678)
4. Rang HP, Dale MM, Ritter JM, Morre PK (2003) Pharmacology. 5th edn. Churchill Livingstone, ISBN-10 / ASIN: 0443071454
5. Caffrey M (2003) Membrane protein crystallization. J Struct Biol 142:108-132 (Pubitemid 36457895)
6. Cherezov V, Clogston J, Papiz MZ, Caffrey M (2006) Room to move: Crystallizing membrane proteins in swollen lipidic mesophases. J Mol Biol 357:1605-1618
7. Cherezov V, Peddi A, Muthusubramaniam L, Zheng YF, Caffrey M (2004) A robotic system for crystallizing membrane and soluble proteins in lipidic mesophases. Acta Crystallogr D Biol Crystallogr 60:1795-1807 (Pubitemid 41079701)
8. Frishman D, Mewes HW (1997) Protein structural classes in fi ve complete genomes. Nat Struct Biol 4:626-628 (Pubitemid 27323443)
9. Wallin E, von Heijne G (1998) Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci 7:1029-1038 (Pubitemid 28216544)
10. Bradley P, Misura KM, Baker D (2005) Toward high-resolution de novo structure prediction for small proteins. Science 309:1868-1871 (Pubitemid 41325099)
11. Casadio R, Fariselli P, Martelli PL, Tasco G (2007) Thinking the impossible: How to solve the protein folding problem with and without homologous structures and more. Methods Mol Biol 350:305-320
12. Forrest LR, Tang CL, Honig B (2006) On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins. Biophys J 91:508-517
13. Eddy SR (1998) Profi le hidden markov models. Bioinformatics 14:755-763
14. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped blast and psi-blast: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402 (Pubitemid 27359211)
15. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G (2009) Structure of p-glycoprotein reveals a molecular basis for poly-specifi c drug binding. Science 323: 1718-1722
16. Dawson RJ, Locher KP (2006) Structure of a bacterial multidrug abc transporter. Nature
17. Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E (2005) Crystal structure of a bacterial homologue of na+/cl-dependent neurotransmitter transporters. Nature 437:215-223 (Pubitemid 41294479)
18. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S (2003) Structure and mechanism of the lactose permease of escherichia coli. Science 301:610-615 (Pubitemid 36927939)
19. Ravna AW, Sager G, Dahl SG, Sylte I (2009) Membrane transporters: Structure, function and targets for drug design. In: Napier S, Bingham M (eds) Transporters as targets for drugs vol 4. Topics in medicinal chemistry pp 15-51.
20. Tai K, Fowler P, Mokrab Y, Stansfeld P, Sansom MS (2008) Molecular modeling and simulation studies of ion channel structures, dynamics and mechanisms. Methods Cell Biol 90:233-265
21. Frydenvang K, Lash LL, Naur P, Postila PA, Pickering DS, Smith CM, Gajhede M, Sasaki M, Sakai R, Pentikainen OT, Swanson GT, Kastrup JS (2009) Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iglur5 induced by the high affi nity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine. J Biol Chem 284:14219-14229
22. Hibbs RE, Sulzenbacher G, Shi J, Talley TT, Conrod S, Kem WR, Taylor P, Marchot P, Bourne Y (2009) Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor. EMBO J 28: 3040-3051
23. Wieman H, Tondel K, Anderssen E, Drablos F (2004) Homology-based modelling of targets for rational drug design. Mini Rev Med Chem 4:793-804 (Pubitemid 39149479)
24. Abagyan R, Totrov M, Kuznetsov DN (1994) Icm-a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native comformation. J Comp Chem 15:488-506
25. Vriend G (1990) What if: A molecular modeling and drug design program. J Mol Graph 8:52-56, 29 (Pubitemid 20717037)
26. Levitt M (1992) Accurate modeling of protein conformation by automatic segment matching. J Mol Biol 226:507-533
27. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815 (Pubitemid 24007801)
28. Laskoswki RA, MacArthur MW, Moss DS, Thorton JM (1993) Procheck: A program to check the stereochemical quality of protein structures. J Appl Cryst 26:283-291
29. Hooft RW, Vriend G, Sander C, Abola EE (1996) Errors in protein structures. Nature 381:272
30. Kryshtafovych A, Venclovas C, Fidelis K, Moult J (2005) Progress over the fi rst decade of casp experiments. Proteins 61 Suppl 7:225-236 (Pubitemid 43069977)
31. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic g proteincoupled receptor. Science 318:1258-1265 (Pubitemid 350172884)
32. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: A g protein-coupled receptor. Science 289:739-745 (Pubitemid 30650186)
33. Kaback HR, Wu J (1997) From membrane to molecule to the third amino acid from the left with a membrane transport protein. Q Rev Biophys 30:333-364 (Pubitemid 28260613)
34. Ward A, Reyes CL, Yu J, Roth CB, Chang G (2007) Flexibility in the abc transporter msba: Alternating access with a twist. Proc Natl Acad Sci U S A 104:19005-19010
35. Higgins CF, Linton KJ (2001) Structural biology. The xyz of abc transporters. Science 293:1782-1784 (Pubitemid 32845767)
36. Oswald C, Holland IB, L. S (2006) The motor domains of abc-transporters-what can structures tell us? Naunyn-Schmiedeberg's Arch Pharmacol 372:385-399
37. Ravna AW, Sylte I, Sager G (2007) Molecular model of the outward facing state of the human p-glycoprotein (abcb1), and comparison to a model of the human mrp5 (abcc5). Theor Biol Med Model 4:33
38. Ravna AW, Sager G (2008) Molecular model of the outward facing state of the human multidrug resistance protein 4 (mrp4/abcc4). Bioorg Med Chem Lett 18:3481-3483 (Pubitemid 351787578)
39. Ravna AW, Sylte I, Sager G (2008) A molecular model of a putative substrate releasing conformation of multidrug resistance protein 5 (mrp5). Eur J Med Chem 43:2557-2567
40. Ravna AW, Sylte I, Sager G (2009) Binding site of abc transporter homology models confi rmed by abcb1 crystal structure. Theor Biol Med Model 6:20
41. Loo TW, Bartlett MC, Clarke DM (2003) Methanethiosulfonate derivatives of rhodamine and verapamil activate human p-glycoprotein at different sites. J Biol Chem 278: 50136-50141 (Pubitemid 37548851)
42. Loo TW, Bartlett MC, Clarke DM (2006) Transmembrane segment 1 of human p-glycoprotein contributes to the drug-binding pocket. Biochem J 396:537-545 (Pubitemid 44228168)
43. Loo TW, Bartlett MC, Clarke DM (2006) Transmembrane segment 7 of human p-glycoprotein forms part of the drug-binding pocket. Biochem J
44. Loo TW, Clarke DM (2002) Location of the rhodamine-binding site in the human multidrug resistance p-glycoprotein. J Biol Chem 277:44332-44338 (Pubitemid 36157868)
45. Loo TW, Clarke DM (2005) Recent progress in understanding the mechanism of p-glycoprotein-mediated drug effl ux. J Membr Biol 206:173-185 (Pubitemid 43199136)
46. Muller M, Mayer R, Hero U, Keppler D (1994) Atp-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 p-glycoprotein. FEBS Lett 343:168-172 (Pubitemid 24126669)
47. Orlowski S, Garrigos M (1999) Multiple recognition of various amphiphilic molecules by the multidrug resistance p-glycoprotein: Molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs. Anticancer Res 19:3109-3123 (Pubitemid 30042598)
48. Smit JW, Duin E, Steen H, Oosting R, Roggeveld J, Meijer DK (1998) Interactions between p-glycoprotein substrates and other cationic drugs at the hepatic excretory level. Br J Pharmacol 123:361-370 (Pubitemid 28059704)
49. Wang EJ, Lew K, Casciano CN, Clement RP, Johnson WW (2002) Interaction of common azole antifungals with p glycoprotein. Antimicrob Agents Chemother 46:160-165 (Pubitemid 34031618)
50. Borst P, de Wolf C, van de Wetering K (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pfl ugers Arch 453:661-673 (Pubitemid 46192537)
51. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profi le of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258 (Pubitemid 28022649)
52. Beuming T, Shi L, Javitch JA, Weinstein H (2006) A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/ na+ symporters (nss) aids in the use of the leut structure to probe nss structure and function. Mol Pharmacol
53. Ravna AW, Sylte I, Dahl SG (2009) Structure and localisation of drug binding sites on neurotransmitter transporters. J Mol Model
54. Singh SK, Yamashita A, Gouaux E (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448:952-956 (Pubitemid 47312772)
55. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, Wang DN (2007) Leutdesipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:1390-1393 (Pubitemid 47417479)
56. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci U S A 89:7782-7785
57. Lee SH, Chang MY, Lee KH, Park BS, Lee YS, Chin HR, Lee YS (2000) Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fl uorophenyl) tropane binding of dopamine transporter. Mol Pharmacol 57:883-889 (Pubitemid 30253370)
58. Chen JG, Sachpatzidis A, Rudnick G (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327 (Pubitemid 27517776)